A novel chromosomal translocation t(4; 14)(p16.3;q32) in multiple myeloma involves the fibroblast growth-factor receptor 3 gene

Blood

Volumn 90, Issue 10, 1997, Pages 4062-4070

  Richelda, Raffaella ^b   Ronchetti, Domenica ^b   Baldini, Luca ^b   Cro, Lilla ^b   Viggiano, Luigi ^b   Marzella, Rosalia ^b   Rocchi, Mariano ^b   Otsuki, Takemi ^b   Lombardi, Luigia ^b   Maiolo, Anna Teresa ^b   Neri, Antonino ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR; IMMUNOGLOBULIN HEAVY CHAIN; MESSENGER RNA;

AMINO ACID SUBSTITUTION; ARTICLE; CARCINOGENESIS; CHROMOSOME 14Q; CHROMOSOME TRANSLOCATION 4; FLUORESCENCE IN SITU HYBRIDIZATION; GENE REARRANGEMENT; GENETIC LINKAGE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MOLECULAR CLONING; MULTIPLE MYELOMA; PRIORITY JOURNAL; SOUTHERN BLOTTING;

EID: 0030842266     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.10.4062     Document Type: Article

References (57)

1. Baiorgie B, Epstein J, Sevanayagam P, Alexanian R: Plasma-cell myeloma: New biological insights and advances in therapy. Blood 73:865, 1989
2. Mandelli F (ed): Baillière's Clinical Hematology: Multiple Myeloma. London, UK, Baillière Tindall, 1995
3. Neri A, Murphy JP, Cro L, Ferrero D, Tarella C, Baldini L, Dalla-Favera R: RAS oncogenes mutation in multiple myeloma. J Exp Med 170:1715, 1989
4. Corradini P, Ladetto M, Voena C, Palumbo A, Inghirami G, Knowles DM, Boccadoro M, Pileri A: Mutational activation of N-and K-ras oncogenes in plasma cell dyscrasias. Blood 81:2708, 1993
5. Neri A, Baldini L, Trecca D, Cro L, Polli E, Maiolo AT: p53 gene mutations in multiple myeloma are associated with advanced forms of malignancy. Blood 81:128, 1993
6. Gaidano G, Dalla-Favera R: Molecular biology of lymphomas, in De Vita VT, Hellman S, Rosenberg SA (eds): Cancer: Principles and Practice of Oncology. Philadelphia, PA, Lippincott, 1997, p 2131
7. Dalla-Favera R, Bregni M, Erickson D, Patterson D, Gallo RC, Croce CM: Human c-myc oncogene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc Natl Acad Sci USA 79:7824, 1982
8. Bakhshi A, Jensen JP, Goldman P, Wright JJ, McBride OW, Epstein AL, Korsmeyer SJ: Cloning the chromosomal breakpoint of t(14; 18) human lymphomas: Clustering around JH on chromosome 14 and near a transcriptional unit on 18. Cell 41:889, 1985
9. Cleary ML, Sklar J: Nucleotide sequence of a t(14; 18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18. Proc Natl Acad Sci USA 82:7439, 1985
10. Tsujimoto Y, Yunis J, Onorato-Showe L, Erikson J, Nowell PC, Croce CM: Molecular cloning of chromosomal breakpoint of B-cell lymphomas and leukemias with the t(11; 14) chromosomal translocation. Science 224:1403, 1984
11. Motokura T, Bloom T, Kim HG, Juppner H, Ruderman JV, Kronenberg HM, Arnold A: A novel cyclin encoded by a bcl-1 linked candidate oncogene. Nature 350:512, 1991
12. Heim S, Mitelman F: Cancer Cytogenetics. New York, NY, Wiley-Liss, 1995
13. Dewald GW, Jenkins RB: Cytogenetic studies of patients with monoclonal gammopathies, in Wiernik PH, Canellos GP, Dutcher JP, Kyle RA (eds): Neoplastic Diseases of the Blood. New York, NY, Churchill Livingstone, 1996, p 515
14. Fielder W, Weh HJ, Hossfeld DK: Comparison of chromosome analysis and BCL-1 rearrangement in a series of patients with multiple myeloma. Br J Haematol 81:58, 1992
15. Seto M, Yamamoto K, Iida S, Akao Y, Utsumi KR, Kubonishi I, Myoshi I, Otsuki T, Yawata Y, Namba M, Motokura T, Arnold A, Takahashi T, Ueda R: Gene rearrangement and overexpression of PRAD1 in lymphoid malignancy with t(11;14)(q13;q32) translocation. Oncogene 7:1401, 1992
16. Meeus P, Stul MS, Mecucci C, Cassiman JJ, Van Den Berghe H: Molecular breakpoints of t(11;14)(q13;q32) in multiple myeloma. Cancer Genet Cytogenet 83:25, 1995
17. Raynaud SD, Bekri S, Leroux D, Grosgeorge J, Klein B, Bastard C, Gaudray P, Simon M-P: Expanded range of 11 breakpoints with differing patterns of cyclin D1 expression in B-cell malignancies. Genes Chrom Cancer 8:80, 1993
18. Chesi M, Bergsagel PL, Brents LA, Smith CM, Gerhard DS, Kuehl WM: Dysregulation of cyclin D1 by translocation into an IgH gamma switch region in two multiple myeloma cell lines. Blood 88:674, 1966
19. Taub R, Kirsch I, Morton C, Lenoir G, Swan D, Tronick S, Aaronson S, Leder P: Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma. Proc Natl Acad Sci USA 79:7837, 1982
20. Neri A, Barriga F, Knowles DM, Magrath I, Dalla-Favera R: Different regions of the immunoglobulin heavy-chain locus are involved in chromosomal translocations in distinct pathogenetic forms of Burkitt lymphoma. Proc Natl Acad Sci USA 85:2748, 1988
21. Shiramizu B, Barriga F, Neequaye J, Jafri A, Dalla-Favera R, Neri A, Guttierez M, Levine P, Magrath I: Patterns of chromosomal breakpoint locations in Burkitt's lymphoma: Relevance to geography and Epstein-Barr virus association. Blood 77:1516, 1991
22. Baxendale S, MacDonald ME, Mott R, Francis F, Lin C, James M, Zehetner G, Hummerich H, Valdes J, Collins FS, Deaven LJ, Gusella JF, Lehrach H, Bates GP: A cosmid conting and high resolution restriction map of the 2 megabase region containing the Huntington's disease gene. Nat Genet 4:181, 1993
23. Thompson LM, Plummer S, Schalling M, Altherr MR, Gusella JF, Housman DE, Wasmuth JJ: A gene encoding a fibroblast growth factor receptor isolated from the Huntington disease gene region of human chromosome 4. Genomics 11:1133, 1991
24. Durie BGM, Salmon S: A clinical staging system for multiple myeloma. Cancer 36:842, 1975
25. Namba M, Otsuki T, Mori M, Togawa A, Wada H, Sugihara T, Yawata Y, Kimoto T: Establishment of five human myeloma cell lines. In Vitro Cell Dev Biol 25:723, 1989
26. Sambrook J, Fritch EF, Maniatis T: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1989
27. Ravetch JV, Siebenlist U, Korsmeyer SJ, Waldmann TA, Leder P: Structure of the human immunoglobulin mu locus: Characterization of embryonic and rearranged J and D genes. Cell 27:583, 1981
28. Showe LC, Ballantine M, Nishikura K, Erikson J, Kaji H, Croce CM: Cloning and sequencing of a c-myc oncogene in a Burkitt's lymphoma cell line that is translocated to a germ line alpha switch region. Mol Cell Biol 5:501, 1985
29. Hamlyn PH, Rabbits TH: Translocation joins c-myc and immunoglobulin gamma-1 genes in a Burkitt's lymphoma revealing a third exon in the c-myc oncogene. Nature 304:135, 1983
30. Pananen J, Makela PT, Eerola E, Korhonen J, Hirvonen H, Claesson-Welsh L, Alitalo K: FGFR-4, a novel acidic fibroblast growth factor receptor with a distinct expression pattern. EMBO J 10:1347, 1991
31. Perez-Castro AV, Wilson J, Altherr MR: Genomic organization of the human fibroblast growth factor receptor 3 (FGFR3) gene and comparative sequence analysis with the mouse fgfr3 gene. Genomics 41:10, 1997
32. Shiang R, Thompson LM, Zhu YZ, Church DM, Fielder TJ, Bocian M, Winckur ST, Wasmuth JJ: Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell 78:335, 1994
33. Keegan K, Johnson DE, Williams LT, Hayman MJ: Isolation of an additional member of the fibroblast growth factor receptor family, FGFR-3. Proc Natl Acad Sci USA 88:1095, 1991
34. Lichter P, Tang Chang C-J, Call K, Hermanson G, Evans GA, Housman D, Ward DC: High resolution mapping of human chromosome 11 by in situ hybridization with cosmid clones. Science 247:64, 1990
35. Antonacci R, Marzella R, Finelli P, Lonoce A, Forabosco A, Archidiacono N, Rocchi M: A panel of subchromosomal painting libraries representing over 300 regions of the human genome. Cytogenet Cell Genet 68:25, 1995
36. Baldini A, Ward DC: In situ hybridization of human chromosomes with Alu-PCR products: A simultaneous karyotype for gene mapping studies. Genomics 9:770, 1991
37. Bergsagel PL, Chesi M, Nardini E, Brents LA, Kirby SL, Kuehl WM: Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma. Proc Natl Acad Sci USA 93:13931, 1996
38. Laffan M, Luzzatto L: Anomalous rearrangements of the immunoglobulin heavy chain genes in human leukemias support the loop-out mechanism of class switch. J Clin Invest 90:2299, 1992
39. Gribbin TE, Stein CK, Harrison JS, Glover TW, Hanson CA, Wasmuth JJ, Cody RL, Mitchell BS: Association of a mature B cell leukemia with a 4p+ chromosomal abnormality: Derivation and characterization of a cell line. Leukemia 3:643, 1989
40. Callet-Bauchu E, Rimkh R, Tigaud I, Pagès J, Gazzo S, Bastion Y, Sebban C, Magaud J-P, Coiftier B, Felman P: dic(4; 17)(p11:p11): A new recurrent chromosomal abnormality in chronic B-lymphoid disorders. Genes Chrom Cancer 17:185, 1996
41. Iida S, Rao PH, Nallasivam P, Hibshoosh H, Butler M, Louie DC, Dyomin V, Ohno H, Chaganli RSK, Dalla-Favera R: The t(9; 14)(p13;q32) chromosomal translocation associated with lymphoplasmacytoid lymphoma involves the PAX-5 gene. Blood 88:4110, 1996
42. Johnson DE, Williams LT: Structural and functional diversity in the fgf receptor multigene family. Adv Cancer Res 60:1, 1993
43. Basilica C, Moscatelli D: The FGF family of growth factors and oncogenes. Adv Cancer Res 59:115, 1992
44. Peters K, Ornitz D, Werner S, Williams L: Unique expression of the FGF receptor 3 gene during mouse organogenesis. Dev Biol 155:423, 1993
45. Gabbianelli M, Sargiacoma M, Pelosi E, Testa U, Isacchi G, Peschle C: "Pure" human hematopoietic progenitors: Permissive action of basic fibroblast growth factor. Science 249:1516, 1990
46. Tavormina PL, Shiang R, Thompson LM, Zhu YZ, Wilkin DJ, Lachman RS, Wilcox WR, Rimoin DL, Cohn DH, Wasmuth JJ: Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3. Nat Genet 9:321, 1995
47. Muenke M, Schell U: Fibroblast-growth-factor receptor mutations in human skeletal disorders. Trends Genet 11:308, 1995
48. Webster MK, Donoghue DJ: Constitutive activation of fibroblast growth factor receptor 3 by the transmembrane domain point mutation found in achondroplasia. EMBO J 15:520, 1996
49. Naski MC, Wang Q, Xu J, Ornitz DM: Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia. Nat Genet 13:233, 1996
50. Webster MK, d'Avis PY, Robertson SC, Donoghue DJ: Profound ligand-independent kinase activation of fibroblast growth factor receptor 3 by the activation loop mutation responsible for a lethal skeletal dysplasia, thanatophoric dysplasia type II. Mol Cell Biol 16:4081, 1996
51. Bergsagel PL, Chesi M, Lim R, Nardini E, Kuehl WM: Dys-regulation of fibroblast growth factor receptor 3 (FGFR3) by t(4; 14)(p16.3;q32.3) in multiple myeloma. Blood 88:634a, 1996 (abstr)
52. Madisen L, Groudine M: Identification of a locus control region in the immunoglobulin heavy-chain locus that regulates c-myc expression in plasmacytoma and Burkitt's lymphoma cell. Genes Dev 8:2212, 1994
53. Pelicci PG, Knowles DM, Magrath I, Dalla-Favera R: Chromosomal breakpoints and structural alterations of the c-myc locus differ in endemic and sporadic forms of Burkitt lymphoma. Proc Natl Acad Sci USA 83:2984, 1986
54. Migliazza A, Martinotti S, Chen W, Fusco C, Ye BH, Knowles DM, Offit K, Chaganti RSK, Dalla-Favera R: Frequent somatic hypermutation of the 5′ non coding region of the BCL6 gene in B-cell lymphoma. Proc Natl Acad Sci USA 92:12520, 1995
55. Lombardi L, Newcomb E, Dalla-Favera R: Pathogenesis of Burkitt lymphoma: Expression of an activated c-myc oncogene causes the tumorigenic conversion of EBV-infected human B lymphoblasts. Cell 49:161, 1987
56. Seremetis S, Inghirami G, Ferrero D, Newcomb E, Knowles DM, Dotto G-P, Dalla-Favera R: Transformation and plasmocytoid differentiation of EBV-infected human B lymphoblasts by ras oncogenes. Science 243:660, 1989
57. Chesi M, Nardini E, Brents LA, Schröck E, Ried T, Kuehl WM, Bergsagel PL: Frequent translocation t(4; 14)(p16.3;q32) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3. Nat Gen 16:260, 1997